TheEdgeResearch
Home / Stocks / LXXGF

LexaGene Holdings Inc. (LXXGF)

OTC Healthcare Medical - Devices
$0.08 ▲ +0.00%
Market Cap
$11.3M
Sector
Healthcare
Industry
Medical - Devices
Beta
2.04
52-Wk Range
0.04963-0.2213
CEO
John F. Regan
Country
US
Currency
USD

LexaGene Holdings Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Beverly, MA, US. The stock last traded at $0.08, up 0.00% on the session, giving a market capitalisation of $11.3M. On trailing twelve-month figures it carries a trailing P/E of -0.90, a net margin of -14101.0%. Its beta of 2.04 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.90
Price / Sales
150.51
Price / Book
1.52
EV / EBITDA
-0.78
Gross margin
-621.4%
Operating margin
-14124.9%
Net margin
-14101.0%
Return on equity
—
Debt / equity
0.20
Current ratio
7.12
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
33
IPO date
—
Headquarters
Beverly, MA, US
About LexaGene Holdings Inc.

LexaGene Holdings Inc. is a biotechnology company focused on developing and commercializing sophisticated systems for pathogen detection. Their flagship product, MiQLab, is an automated platform engineered to transform pathogen identification within diverse markets, including veterinary and human clinical diagnostics, food and water safety, and various other life science applications. This advanced, automated system is deployed directly at the point of sample collection, offering unparalleled ease of use, high sensitivity, and the capacity to detect a wide range of pathogens. Founded in 2007, the company's headquarters are located in Beverly, Massachusetts.

Comparable companies

LexaGene Holdings Inc. is most often compared with the following Healthcare names:

ATBPFAVEFFCDXFFCNPOFEIGRQLVCLYMGCLFRXMDTMDIFVRCDF
More research on LXXGF
LXXGF technical analysis LXXGF TheEdge Score Compare against peers
Open full interactive analysis & DCF →